对4'-(9-吖啶基氨基)-甲磺酰间茴香胺耐药的P388白血病亚系的发育及交叉耐药特性 - Suppr

Suppr

超能文献

Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

作者信息

Johnson R K, Howard W S

出版信息

Eur J Cancer Clin Oncol. 1982 May;18(5):479-87. doi: 10.1016/0277-5379(82)90117-1.

DOI:10.1016/0277-5379(82)90117-1

PMID:6956514

Abstract

摘要

相似文献

Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Eur J Cancer Clin Oncol. 1982 May;18(5):479-87. doi: 10.1016/0277-5379(82)90117-1.

Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.

Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1605-9. doi: 10.1016/0360-3016(79)90782-x.

m-AMSA as a probe for transport phenomena associated with anthracycline resistance.

Biochem Pharmacol. 1984 Apr 1;33(7):991-3. doi: 10.1016/0006-2952(84)90505-7.

Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in mice.

Eur J Cancer Clin Oncol. 1983 Nov;19(11):1607-13. doi: 10.1016/0277-5379(83)90093-7.

Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.

Biochem Biophys Res Commun. 1985 Sep 16;131(2):912-9. doi: 10.1016/0006-291x(85)91326-9.

Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.

Cancer Res. 1986 Jul;46(7):3330-3.

Potential antitumor agents. 52. Carbamate analogues of amsacrine with in vivo activity against multidrug-resistant P388 leukemia.

J Med Chem. 1987 Sep;30(9):1576-81. doi: 10.1021/jm00392a009.

Schedule dependence of activity of the amsacrine analogue CI-921 towards P388 leukaemia and Lewis lung carcinoma.

Eur J Cancer Clin Oncol. 1985 Nov;21(11):1337-41. doi: 10.1016/0277-5379(85)90314-1.

Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA).

Cancer Chemother Pharmacol. 1982 Dec;10(1):27-8. doi: 10.1007/BF00257232.

Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.

Cancer Res. 1985 Apr;45(4):1687-91.

引用本文的文献

Topoisomerase II in multiple drug resistance.

Cytotechnology. 1993;12(1-3):137-54. doi: 10.1007/BF00744662.

In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).

Br J Cancer. 1989 Dec;60(6):838-44. doi: 10.1038/bjc.1989.376.

Characterization of an etoposide-resistant human K562 cell line, K/eto.

Jpn J Cancer Res. 1991 Sep;82(9):1035-43. doi: 10.1111/j.1349-7006.1991.tb01940.x.

Cross-resistance of drug-resistant murine P388 leukemias to taxol in vivo.

Cancer Chemother Pharmacol. 1992;31(3):255-7. doi: 10.1007/BF00685557.

Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.

Cancer Chemother Pharmacol. 1992;31(1):46-52. doi: 10.1007/BF00695993.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验